Two precursor lesions for testicular germ cell tumors type II, germ cell neoplasia in situ (GCNIS) and microinvasive germ cell tumor (MGCT) (Figure 1b) [5,6], and seminoma (SE) also express an OSKM panel, with SOX17 as substitute for SOX2. This evidence concerns the gene SOX17 and seminoma.